Newsbenzinga
$100 Invested In Axsome Therapeutics 10 Years Ago Would Be Worth This Much Today
· Published
Article summary
Axsome Therapeutics (NASDAQ:AXSM) has outperformed the market over the past 10 years by 24.39% on an annualized basis producing an average annual return of 37.87%. Currently, Axsome Therapeutics has a market
An excerpt from the original article.
Comments —
Loading comments…